Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study. (Q51333570)
Jump to navigation
Jump to search
scientific article published on 28 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study. |
scientific article published on 28 October 2013 |
Statements
1 reference
Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study. (English)
1 reference
William T Cefalu
1 reference
Kaj Stenlöf
1 reference
Kyoung-Ah Kim
1 reference
Esteban Jodar
1 reference
Maria Alba
1 reference
Robert Edwards
1 reference
Cindy Tong
1 reference
William Canovatchel
1 reference
Gary Meininger
1 reference
28 October 2013
1 reference
30
1 reference
163-175
1 reference
2
1 reference
Identifiers
1 reference